A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial Scaffold
ACS Medicinal Chemistry Letters2012Vol. 3(5), pp. 373–377
Citations Over TimeTop 10% of 2012 papers
Félix Calderón, Jaume Vidal-Mas, Jeremy N. Burrows, Juan Carlos de la Rosa, Marı́a Belén Jiménez-Dı́az, Teresa Mulet, Sara Prats, J. Solana, Michael J. Witty, Francisco‐Javier Gamo, Esther Fernández
Abstract
From the 13 533 chemical structures published by GlaxoSmithKline in 2010, we identified 47 quality starting points for lead optimization. One of the most promising hits was the TCMDC-139046, a molecule presenting an indoline core, which is well-known for its anxiolytic properties by interacting with serotonin antagonist receptors 5-HT2. The inhibition of this target will complicate the clinical development of these compounds as antimalarials. Herein, we present the antimalarial profile of this series and our efforts to avoid interaction with this receptor, while maintaining a good antiparasitic potency. By using a double-divergent structure-activity relationship analysis, we have obtained a novel lead compound harboring an indoline core.
Related Papers
- → Design and Synthesis of Natural Product Inspired Libraries Based on the Three-Dimensional (3D) Cedrane Scaffold: Toward the Exploration of 3D Biological Space(2018)30 cited
- → Synthesis of the TACO Scaffold as a New Selectively Deprotectable Conformationally Restricted Triazacyclophane Based Scaffold(2014)2 cited
- → 216 Basic Study of Scaffold Creation for Organ Regeneration with Using 3D Printer(2014)
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)